Hirsutism

  • M. Breckwoldt
  • H. P. Zahradnik
  • P. Wieacker

Abstract

Hirsutism must be regarded as an androgen-mediated symptom. In men virilization is a normal occurrence at puberty and is closely related to an increase in testicular function, but in women virilization is an unnatural phenomenon. The clinical spectrum of virilization includes acne, seborrhea oleosa, hirsutism, androgenetic alopecia, and more severe manifestations such as deepening of the voice, clitorimegaly, and pectoral muscle hypertrophy. The clinical picture of hirsutism may range from mild beard growth to increased coarse body hair of the male type, with or without menstrual disorders. The pathogenesis of hirsutism is apparently linked to androgenic hormones. The physiological role of androgens, namely testosterone, is well defined in men: testosterone is involved in genital development, the process of sperm maturation, the regulation of gonadotropin secretion by the pituitary, the growth of sexual hair, and the regulation of sexuality; moreover, it represents a most potent anabolic hormone.

Keywords

Acne Zucker Androstenedione Hypospadia Aromatization 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham GE (1974) Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 39:340–346PubMedCrossRefGoogle Scholar
  2. Abraham GE, Chakmakjian ZH (1973) Serum steroid levels during the menstrual cycle in a bilaterally adrenalectomized women. J Clin Endocrinol Metab 37:581–587PubMedCrossRefGoogle Scholar
  3. Abraham GE, Maroulis GB, Buster JE, Chang RJ, Marshall JR (1976) Effect of dexamethasone on serum Cortisol and androgen levels in hirsute patients. Obstet Gynecol 47:395–402PubMedGoogle Scholar
  4. Anderson KM, Liao S (1968) Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219:277–279PubMedCrossRefGoogle Scholar
  5. Andreson DC (1976) The role of sex hormone binding globuline in health and disease. In: James VHT, Serio M, Giusti G (eds) The endocrine function of the human ovary. Academic, LondonGoogle Scholar
  6. Apostolakis M, Tamm J, Voigt KD (1966) Testosteron und Behaarung. Med Klin 61:212–215PubMedGoogle Scholar
  7. Bardin CW, Lipsett MB (1967) Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 46:891–902PubMedCrossRefGoogle Scholar
  8. Bardin CW, Mahoudeau JA (1970) Dynamics of androgen metabolism in women with hirsutism. Ann Clin Res 2:251–262PubMedGoogle Scholar
  9. Bissel GW (1951) Hirsutism. Ann NY Acad Sci 53:742CrossRefGoogle Scholar
  10. Bruchovsky N, Wilson JD (1968) The intranuclear binding of testosterone and 5a-androstan-17β-ol-3-one by rat prostate. J Biol Chem 243:5953–5960PubMedGoogle Scholar
  11. Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol 21:1440–1447CrossRefGoogle Scholar
  12. Flamigni C, Collins WP, Koullapnis EN, Craft I, Dewhurst CJ, Sommerville IF (1971) Androgen metabolism in human skin. J Clin Endocrinol Metab 32:737–743PubMedCrossRefGoogle Scholar
  13. Gallegos AJ, Berliner DL (1967) Transformation and conjugation of dehydroepiandrosterone by human skin. J Clin Endocrinol Metab 27:1214–1218PubMedCrossRefGoogle Scholar
  14. Gehring U, Tomkins GM, Ohno S (1971) Effect of the androgen-insensitive mutation on a cytoplasmic receptor for dihydrotestosterone. Nature 232:106–107Google Scholar
  15. Geisthövel F, Rieger B, Geyer H, Peters F, Sandow J (1986) Effect of long-term s.c. infusion of a Gn-RH agonist (Buserelin) on pituitary and ovarian function. Acta Endocrinol Copenh [Suppl] 274:90Google Scholar
  16. Gloyna RE, Wilson JD (1969) A comparative study of the conversion of testosterone to 17β-hydroxy-5α-androstan-3-one (DHT) by prostate and epidihymis. J Clin Endocrinol 29:970–977CrossRefGoogle Scholar
  17. Gomez EC, Hsia SL, Frost P (1972) Cutaneous transformation of testosterone into 5α-andros-tane-3β, 17β-diol. J Clin Endocrinol 34:417–419CrossRefGoogle Scholar
  18. Heinrichs WL, Karsenia R, Wyss R, Lehmann WL (1969) Testicular feminization an apparent enzyme defect. Clin Res 17:143Google Scholar
  19. Horton R, Tait JF (1966) Androstendione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest 45:301–313PubMedCrossRefGoogle Scholar
  20. Horton RD, Tait JF (1967) In-vivo conversion of DHE A to plasma androstendione and testosterone in man. J Clin Endocrinol Metab 27:79–88PubMedCrossRefGoogle Scholar
  21. Ismail AAA, Davidson DW, Souka AR, Barnes EW, Irvine WJ, Kilimnik H, Vanderbeeken Y (1974) The evaluation of the role of androgens in hirsutism and the use of a new antiandrogen “cyproterone acetate” for therapy. J Clin Endocrinol Metab 39:81–95PubMedCrossRefGoogle Scholar
  22. Ito T, Horton R (1970) Dihydrotestosterone in human peripheral plasma. J Clin Endocrinol Metab 31:362–368PubMedCrossRefGoogle Scholar
  23. Jenkins JS, Ash S (1973) The metabolism of testosterone in skin of normal subjects and in testicular feminization. J Endocrinol 59:345–351PubMedCrossRefGoogle Scholar
  24. Kaiser R, Karl HJ, Daume E (1963) Zyklusstörungen und Hirsutismus. Geburtshilfe Frauenheilkd 23:593–614Google Scholar
  25. Keenan BS, Meyer WJ, Hadjian A J, Jones HW, Migeon CJ (1974) Syndrome of androgen insensitivity: absence of 5α-DHT binding protein in skin fibroblasts. J Clin Endocrinol Metab 38:1143–1146PubMedCrossRefGoogle Scholar
  26. Keenan BS, Meyer WJ, Hadjian AJ, Migeon CJ (1975) Androgen receptor in human skin fibroblasts. Characterization of a specific 17β-hydroxy-5a-androstan-3-one protein complex in cell sonicates and nuclei. Steroids 25:535–552PubMedCrossRefGoogle Scholar
  27. Kim MH, Hosseinian AH, Dupon C (1974) Plasma levels of estrogens, androgens and progesterone during normal and dexamethasone treated cycles. J Clin Endocrinol Metab 39:706–712PubMedCrossRefGoogle Scholar
  28. Kirschner MA, Jacobs JB (1971) Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen overproduction in hirsute women. J Clin Endocrinol Metab 33:199–209PubMedCrossRefGoogle Scholar
  29. Kirschner MA, Bardin CW, Hembree WC, Ross GT (1970) Effect of estrogen administration on androgen production and plasma luteinizing hormone in hirsute women. J Clin Endocrinol 30:727–732CrossRefGoogle Scholar
  30. Kirschner MA, Sinhamahapatra S, Zucker TR, Loriaux L, Nieschlag E (1973) The production, origin and role of DHEA and 5androgenediol as androgen prehormones in hirsute women. J Clin Endocrinol Metab 37:183–189PubMedCrossRefGoogle Scholar
  31. Kirschner MA, Zucker IR, Jespersen DL (1976) Ovarian and adrenal vein catheterization studies in women with idiopathic hirsutism. In: James VHT, Serio M, Giusti G (eds) The endocrine function of the human ovary. Academic, LondonGoogle Scholar
  32. Kuttenn F, Mauvais-Jarvis P (1975) Testosterone 5a-reduction in the skin of normal subjects and of patients with abnormal sex development. Acta Endocrinol (Copenh) 79:164–176Google Scholar
  33. Lloyd CW, Lobotsky J, Baird DT, Mracken JA, Weisz J, Pupkin M, Janarti J, Puga J (1971) Concentration of unconjugated estrogens, androgens and gestagens in ovarian and peripheral venous plasma of women: the normal menstrual cycle. J Clin Endocrinol Metab 32:155–166PubMedCrossRefGoogle Scholar
  34. Lobo RA, Goebelsmann U, Hortin R (1983) Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 57:393–397PubMedCrossRefGoogle Scholar
  35. Ludwig E (1969) Hypertrichosen und Hirsutismus. Z Allgemeinmed Landarzt 45:754–762Google Scholar
  36. Mainwaring WIP (1969) A soluble androgen receptor in the cytoplasma of rat prostate. J Endocrinol 45:531–541PubMedCrossRefGoogle Scholar
  37. Mauvais-Jarvis P, Charransol G, Bobas-Msson F (1973) Simultaneous determination of urinary androstandiol and testosterone as an evaluation of human androgenicity. J Clin Endocrinol Metab 36:452–459PubMedCrossRefGoogle Scholar
  38. Mauvais-Jarvis P, Kutten F, Mowszowicz I (1981) Hirsutism. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  39. McKnight E (1964) The prevalence of “hirsutism” in young women. Lancet 1:410–413PubMedCrossRefGoogle Scholar
  40. Mercier-Bodard C, Alfsen A, Baulieu EE (1970) Sex steroid binding plasma protein (SBP). Acta Endocrinol Copenh [Suppl] 147:204Google Scholar
  41. Mikhail G (1967) Sex steroids in blood. Clin Obstet Gynecol 10:29–39PubMedCrossRefGoogle Scholar
  42. Mowszowicz I, Kahn D, Dray F (1970) Influence of testosterone binding to serum proteins on aromatization by enzymes of human placental microsomes. J Clin Endocrinol Metab 31:584–586PubMedCrossRefGoogle Scholar
  43. Mowszowicz I, Melanitous E, Doukani A, Wright F, Kutten F, Mauvais-Jarvis P (1983) Androgen binding capacity and 5a reductase activity in pubic skin fibroblasts from hirsute patients. J Clin Endocrinol Metab 56:1209–1213PubMedCrossRefGoogle Scholar
  44. Mulay S, Finkelberg R, Pinsky L, Solomon S (1972) Metabolism of 4-14C-testosterone by serially subcultured human skin fibroblasts. J Clin Endocrinol Metab 34:133–143PubMedCrossRefGoogle Scholar
  45. Northcutt RC, Island DP, Liddle GW (1969) An explanation for the target organ unresponsiveness to testosterone in the testicular feminization syndrome. J Clin Endocrinol 29:422–425CrossRefGoogle Scholar
  46. Pinsky L, Kaufman M, Straisfels C, Shanfield B (1974) Lack of difference in testosterone metabolism between cultured skin fibroblasts of human adult males and females. J Clin Endocrinol Metab 39:395–398PubMedCrossRefGoogle Scholar
  47. Rivarola MA, Forest MG, Migeon CJ (1968) Testosterone, androgenedione, dehydroepiandrosterone in plasma during pregnancy and delivery: concentration and protein binding. J Clin Endocrinol 28:34–40CrossRefGoogle Scholar
  48. Rook A (1965) Endocrine influence on hair growth. Br Med J 5435:609–614CrossRefGoogle Scholar
  49. Rosenfield RL (1971) Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metab 32:717–728PubMedCrossRefGoogle Scholar
  50. Rosenfield RL, Otto P (1972) Androstenediol levels in human peripheral plasma. J Clin Endocrinol Metab 35:818–822PubMedCrossRefGoogle Scholar
  51. Sansone G, Reisner RM (1971) Differential rates of conversion of testosterone to dihydrotestosterone in acne and normal skin: a possible pathogenic factor in acne. J Invest Dermatol 56:366–372PubMedCrossRefGoogle Scholar
  52. Schürmeyer T, Wickings EJ, Freischem CW, Nieschlag E (1983) Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men. Acta Endocrinol (Copenh) 102:456–462Google Scholar
  53. Schweikert H, Wilson JD (1974) Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hair. J Clin Endocrinol Metab 38:811–819PubMedCrossRefGoogle Scholar
  54. Shah PN (1957) Human body hair (a quantitative study). Am J Obstet Gynecol 72:1255Google Scholar
  55. Siiteri PK, Wilson JD (1974) Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 38:113–125PubMedCrossRefGoogle Scholar
  56. Southren AL, Gordon GG, Tochimoto S (1968) Further study of factors affecting the metabolic clearance rate of testosterone in man. J Clin Endocrinol 28:1105–1112CrossRefGoogle Scholar
  57. Stahl NL, Teeslink CR, Greenblatt RB (1973) Ovarian adrenal and peripheral testosterone levels in the polycystic ovary syndrome. Am J Obstet Gynecol 117:194–200PubMedGoogle Scholar
  58. Thomas JP, Oake RJ (1974) Androgen metabolism in the skin of hirsute women. J Clin Endocrinol Metab 38:19–22PubMedCrossRefGoogle Scholar
  59. Valette A, Seradour B, Boyer J (1975) Plasma testosterone levels during the menstrual cycle. J Clin Endocrinol Metab 40:160–161PubMedCrossRefGoogle Scholar
  60. Vermeulen A (1977) Transport and distribution of androgens at different ages. In: Martin L, Motta M (Eds) Androgens and antiandrogens. Raven, New YorkGoogle Scholar
  61. Vermeulen A, Verdonck L, Van der Straeten M, Orie N (1969) Capacity of the testosterone binding globulin in human plasma and influence of specific binding of testosterone on its MCR. J Clin Endocrinol 29:1470–1480CrossRefGoogle Scholar
  62. Vermeulen A, Stoica T, Verdonck L (1971) The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab 33:759–767PubMedCrossRefGoogle Scholar
  63. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, Maonald PC, Wilson JD (1974) Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291:944–949PubMedCrossRefGoogle Scholar
  64. Weed JC (1955) Management of hirsutism in the female. Am J Obstet Gynecol 45:1347Google Scholar
  65. Westphal U (1986) Steroid-protein interactions II. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  66. Wilson JD (1975) Dihydrotestosterone formation in cultured human fibroblasts. Comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, type 2. J Biol Chem 250:3498–3504PubMedGoogle Scholar
  67. Wilson JD, Gloyna RE (1970) The intranuclear metabolism of testosterone in the accessory organs of reproductions. Recent Prog Horm Res 26:309–336PubMedGoogle Scholar
  68. Wilson JD, Walker JD (1969) The conversion of testosterone to 5α-androstan-17β-ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest 48:371–379PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • M. Breckwoldt
  • H. P. Zahradnik
  • P. Wieacker

There are no affiliations available

Personalised recommendations